论文部分内容阅读
目的:对干扰素在小儿病毒性上呼吸道感染治疗过程中的应用进行分析,以明确干扰素的治疗效果。方法:随机抽取我院在2012年1月-2013年1月治疗的小儿病毒性上呼吸道感染的病例52例,分为两组:观察组和对照组,两组患者的一个疗程都设置为7天,观察组使用干扰素进行治疗,而对照组则使用利巴韦林注射进行治疗,对治疗效果进行对比。结果:观察组使用的干扰素进行治疗,有效率达到了96.15%,而对照组中的有效率是61.54%,观察组与对照组存在着较大差异,具备统计学意义(P<0.05)。在患儿的退烧时间上也存在较大差异,具备统计学意义(P<0.05)。结论:小儿病毒性上呼吸道感染采用干扰素治疗具有非常明显的优势,且副作用较小,具有很高的安全性和可靠性,值得在临床上进行大范围的推广和应用。
OBJECTIVE: To analyze the application of interferon in the treatment of pediatric viral upper respiratory tract infection in order to clarify the therapeutic effect of interferon. Methods: Fifty-two cases of pediatric viral upper respiratory tract infection in our hospital from January 2012 to January 2013 were randomly selected and divided into two groups: observation group and control group. One course of treatment in both groups was set as 7 Day, the observation group treated with interferon, while the control group was treated with ribavirin injection, the treatment effect was compared. Results: The interferon used in the observation group was 96.15%, while the effective rate in the control group was 61.54%. There was a significant difference between the observation group and the control group (P <0.05). In children with fever on the time there are also significant differences, with statistical significance (P <0.05). Conclusion: The treatment of pediatric viral upper respiratory tract infection with interferon has obvious advantages, with fewer side effects, high safety and reliability, and worthy of wide application and promotion in clinic.